Skip to content
  • Clinical Studies
  • Pharma SOP’s
  • Pharma tips
  • Pharma Books
  • Stability Studies
  • Schedule M

Pharma GMP

Your Gateway to GMP Compliance and Pharmaceutical Excellence

  • Home
  • Quick Guide
  • GMP Failures & Pharma Compliance
    • Common GMP Failures
    • GMP Documentation & Records Failures
    • Cleaning & Sanitation Failures in GMP Audits
    • HVAC, Environmental Monitoring & Cross-Contamination Risks
  • Toggle search form

GMP in India

How Schedule M Revised Influences Risk Management in Indian Pharmaceutical Manufacturing

Posted on January 30, 2025 By digi

How Schedule M Revised Influences Risk Management in Indian Pharmaceutical Manufacturing Exploring the Role of Schedule M Revised in Pharmaceutical Risk Management Introduction to Risk Management and Schedule M Revised Risk management is a cornerstone of Good Manufacturing Practices (GMP) in the pharmaceutical industry. With the revision of Schedule M under the Drugs and Cosmetics…

Read More “How Schedule M Revised Influences Risk Management in Indian Pharmaceutical Manufacturing” »

GMP in India

The Role of Personnel Training in Ensuring Compliance with Schedule M Revised

Posted on January 31, 2025 By digi

The Role of Personnel Training in Ensuring Compliance with Schedule M Revised How to Train Personnel for Schedule M Revised Compliance Introduction to Personnel Training and Schedule M Revised A well-trained workforce is critical to ensuring compliance with Schedule M Revised, the updated guidelines under the Drugs and Cosmetics Rules, 1945. These guidelines emphasize the…

Read More “The Role of Personnel Training in Ensuring Compliance with Schedule M Revised” »

GMP in India

How Schedule M Revised Affects the Manufacturing of Sterile and Parenteral Products in India

Posted on January 31, 2025 By digi

How Schedule M Revised Affects the Manufacturing of Sterile and Parenteral Products in India Understanding the Impact of Schedule M Revised on Sterile and Parenteral Product Manufacturing Introduction to Sterile and Parenteral Manufacturing and Schedule M Revised The production of sterile and parenteral products demands stringent adherence to Good Manufacturing Practices (GMP) to ensure product…

Read More “How Schedule M Revised Affects the Manufacturing of Sterile and Parenteral Products in India” »

GMP in India

How Schedule M Revised Prevents Cross-Contamination in Pharmaceutical Manufacturing

Posted on February 1, 2025 By digi

How Schedule M Revised Prevents Cross-Contamination in Pharmaceutical Manufacturing A Guide to Preventing Cross-Contamination Under Schedule M Revised Introduction to Cross-Contamination and Schedule M Revised Cross-contamination in pharmaceutical manufacturing occurs when one product is contaminated with another product, raw material, or external substance. This can compromise product safety, efficacy, and quality, leading to regulatory non-compliance…

Read More “How Schedule M Revised Prevents Cross-Contamination in Pharmaceutical Manufacturing” »

GMP in India

How to Maintain GMP Compliance Post-Schedule M Revised Inspection

Posted on February 1, 2025 By digi

How to Maintain GMP Compliance Post-Schedule M Revised Inspection Tips for Sustaining GMP Compliance After a Schedule M Revised Inspection Introduction to Post-Inspection Compliance Successfully passing a Schedule M Revised inspection is a critical milestone for pharmaceutical manufacturers, but compliance does not end there. Maintaining Good Manufacturing Practices (GMP) requires continuous monitoring, regular updates to…

Read More “How to Maintain GMP Compliance Post-Schedule M Revised Inspection” »

GMP in India

How Schedule M Revised Supports the Implementation of Good Laboratory Practices (GLP) in India

Posted on February 2, 2025 By digi

How Schedule M Revised Supports the Implementation of Good Laboratory Practices (GLP) in India The Role of Schedule M Revised in Strengthening Good Laboratory Practices (GLP) Introduction to Good Laboratory Practices and Schedule M Revised Good Laboratory Practices (GLP) are a set of principles aimed at ensuring the integrity, reliability, and reproducibility of laboratory data….

Read More “How Schedule M Revised Supports the Implementation of Good Laboratory Practices (GLP) in India” »

GMP in India

The Challenges of Schedule M Revised Compliance for Pharmaceutical Manufacturers in India

Posted on February 2, 2025 By digi

The Challenges of Schedule M Revised Compliance for Pharmaceutical Manufacturers in India Overcoming Challenges in Complying with Schedule M Revised Introduction to Schedule M Revised Compliance The revised Schedule M under the Drugs and Cosmetics Rules, 1945, has introduced stringent Good Manufacturing Practices (GMP) for Indian pharmaceutical manufacturers. These updates align domestic standards with global…

Read More “The Challenges of Schedule M Revised Compliance for Pharmaceutical Manufacturers in India” »

GMP in India

How Schedule M Revised Impacts Pharmaceutical Supply Chain Management in India

Posted on February 3, 2025 By digi

How Schedule M Revised Impacts Pharmaceutical Supply Chain Management in India Understanding the Influence of Schedule M Revised on Pharmaceutical Supply Chains Introduction to Schedule M Revised and Supply Chain Management The pharmaceutical industry relies on robust supply chain management to ensure the availability of safe, effective, and high-quality medicines. With the introduction of Schedule…

Read More “How Schedule M Revised Impacts Pharmaceutical Supply Chain Management in India” »

GMP in India

Understanding the Role of Environmental Control Systems in Schedule M Revised Compliance

Posted on February 3, 2025 By digi

Understanding the Role of Environmental Control Systems in Schedule M Revised Compliance The Importance of Environmental Control Systems in Pharmaceutical Manufacturing Under Schedule M Revised Introduction to Environmental Control Systems and Schedule M Revised Environmental control systems are critical in pharmaceutical manufacturing, ensuring that production environments meet stringent requirements for cleanliness, sterility, and safety. The…

Read More “Understanding the Role of Environmental Control Systems in Schedule M Revised Compliance” »

GMP in India

How to Streamline Pharmaceutical Manufacturing Processes While Ensuring Schedule M Revised Compliance

Posted on February 4, 2025 By digi

How to Streamline Pharmaceutical Manufacturing Processes While Ensuring Schedule M Revised Compliance Step-by-Step Guide to Streamline Manufacturing Processes for Schedule M Revised Compliance Introduction to Process Streamlining and Schedule M Revised In the pharmaceutical industry, efficient manufacturing processes are essential for maintaining product quality, reducing costs, and ensuring compliance with regulatory standards. With the introduction…

Read More “How to Streamline Pharmaceutical Manufacturing Processes While Ensuring Schedule M Revised Compliance” »

GMP in India

Posts pagination

Previous 1 2 3 4 … 6 Next

Quick Guide

  • GMP Basics
    • Introduction to GMP
    • What is cGMP?
    • Key Principles of GMP
    • Benefits of GMP in Pharmaceuticals
    • GMP vs. GxP (Good Practices)
  • Regulatory Agencies & Guidelines
    • WHO GMP Guidelines
    • FDA GMP Guidelines
    • MHRA GMP Guidelines
    • SCHEDULE – M – Revised
    • TGA GMP Guidelines
    • Health Canada GMP Regulations
    • NMPA GMP Guidelines
    • PMDA GMP Guidelines
    • EMA GMP Guidelines
  • GMP Compliance & Audits
    • How to Achieve GMP Certification
    • GMP Auditing Process
    • Preparing for GMP Inspections
    • Common GMP Violations
    • Role of Quality Assurance
  • Quality Management Systems (QMS)
    • Building a Pharmaceutical QMS
    • Implementing QMS in Pharma Manufacturing
    • CAPA (Corrective and Preventive Actions) for GMP
    • QMS Software for Pharma
    • Importance of Documentation in QMS
    • Integrating GMP with QMS
  • Pharmaceutical Manufacturing
    • GMP in Drug Manufacturing
    • GMP for Biopharmaceuticals
    • GMP for Sterile Products
    • GMP for Packaging and Labeling
    • Equipment and Facility Requirements under GMP
    • Validation and Qualification Processes in GMP
  • GMP Best Practices
    • Total Quality Management (TQM) in GMP
    • Continuous Improvement in GMP
    • Preventing Cross-Contamination in Pharma
    • GMP in Supply Chain Management
    • Lean Manufacturing and GMP
    • Risk Management in GMP
  • Regulatory Compliance in Different Regions
    • GMP in North America (FDA, Health Canada)
    • GMP in Europe (EMA, MHRA)
    • GMP in Asia (PMDA, NMPA, KFDA)
    • GMP in Emerging Markets (GCC, Latin America, Africa)
    • GMP in India
  • GMP for Small & Medium Pharma Companies
    • Implementing GMP in Small Pharma Businesses
    • Challenges in GMP Compliance for SMEs
    • Cost-effective GMP Compliance Solutions for Small Pharma Companies
  • GMP in Clinical Trials
    • GMP Compliance for Clinical Trials
    • Role of GMP in Drug Development
    • GMP for Investigational Medicinal Products (IMPs)
  • International GMP Inspection Standards and Harmonization
    • Global GMP Inspection Frameworks
    • WHO Prequalification and Inspection Systems
    • US FDA GMP Inspection Programs
    • EMA and EU GMP Inspection Practices
    • PIC/S Role in Harmonized Inspections
    • Country-Specific Inspection Standards (e.g., UK MHRA, US FDA, TGA)
  • GMP Blog

Latest Posts

  • GMP-cGMP Regulations & Global Standards
    • FDA cGMP Regulations for Drugs & Biologics
    • cGMP Requirements for Pharmaceutical Manufacturers
    • ICH Q7 and API GMP Expectations
    • Global & ISO-Based GMP Standards
    • GMP for Medical Devices & Combination Products
    • GMP for Pharmacies & Hospital Pharmacy Settings
  • Applied GMP in Pharma Manufacturing & Operations
    • GMP for Pharmaceutical Drug Product Manufacturing
    • GMP for Biotech & Biologics Manufacturing
    • GMP Documentation
    • GMP Compliance
    • GMP for APIs & Bulk Drugs
    • GMP Training
  • Computer System Validation (CSV) & GxP Computerized Systems
    • CSV Fundamentals in Pharma & Biotech
    • FDA CSV Guidance & 21 CFR Part 11 Alignment
    • GAMP 5 & Risk-Based Validation Approaches
    • CSV in Pharmaceutical & GxP Industries (Use-Cases & System Types)
    • CSV Documentation
    • CSV for Regulated Equipment & Embedded Systems
  • Data Integrity & 21 CFR Part 11 Compliance
    • Data Integrity Principles in cGMP Environments
    • FDA Data Integrity Guidance & Expectations
    • 21 CFR Part 11 – Electronic Records & Signatures
    • Data Integrity in GxP Computerized Systems
    • Data Integrity Audits
  • Pharma GMP & Good Manufacturing Practice
    • FDA 483, Warning Letters & GMP Inspections
    • Data Integrity, ALCOA+ & Part 11 / Annex 11
    • Process Validation, CPV & Cleaning Validation
    • Contamination Control & Annex 1
    • PQS / QMS / Deviations / CAPA / OOS–OOT
    • Documentation, Batch Records & GDP
    • Sterility, Microbiology & Utilities
    • CSV, GAMP 5 & Automation
    • Dosage-Form–Specific GMP (Solids, Liquids, Sterile, Topicals)
    • Supply Chain, Warehousing, Cold Chain & GDP
Widget Image
  • Never Assign Batch Release Responsibilities to Non-QA Personnel in GMP

    Never Assign Batch Release Responsibilities… Read more

  • Manufacturing & Batch Control
    • GMP manufacturing process control
    • Batch Manufacturing record requirements
    • Master Batch record template for pharmaceuticals
    • In Process control checks in tablet manufacturing
    • Line clearance procedure before batch start
    • Batch reconciliation in pharmaceutical manufacturing
    • Yield reconciliation GMP guidelines
    • Segregation of different strength products GMP
    • GMP controls for high potency products
    • Cross Contamination prevention in manufacturing
    • Line clearance checklist for production
    • Batch documentation review before qa release
    • Process parameters control limits in pharma
    • Equipment changeover procedure GMP
    • Batch manufacturing deviation handling
    • GMP expectations for batch release
    • In Process sampling plan for tablets
    • Visual inspection of dosage forms GMP requirements
    • In Process checks for filled vials
    • Startup and Shutdown procedure for manufacturing line
    • GMP requirements for blending and mixing operations
    • Process Control strategy in pharmaceutical manufacturing
    • Uniformity of dosage units in process controls
    • GMP checklist for oral solid dosage manufacturing
    • Process Control
    • Batch Documentation
    • Master Batch Records
    • In-Process Controls
    • Line Clearance
    • Yield & Reconciliation
    • Segregation & Mix-Ups
    • High Potency Products
    • Cross Contamination Control
    • Line Clearance
    • Batch Review
    • Process Parameters
    • Equipment Changeover
    • Deviations
    • Batch Release
    • In-Process Sampling
    • Visual Inspection
    • In-Process Checks for Vials
    • Start-Up & Shutdown
    • Blending & Mixing
    • Control Strategy
    • Dosage Uniformity
    • Hold Time Studies
    • OSD GMP Checklist
  • Cleaning & Contamination Control
  • Warehouse & Material Handling
    • Warehouse GMP
    • Material Receipt
    • Sampling
    • Status Labelling
    • Storage Conditions
    • Rejected & Returned
    • Reconciliation
    • Controlled Drugs
    • Dispensing
    • FIFO & FEFO
    • Cold Chain
    • Segregation
    • Pest Control
    • Env Monitoring
    • Palletization
    • Damaged Containers
    • Stock Verification
    • Sampling & Weighing Areas
    • Issue to Production
    • Traceability
    • Printed Materials
    • Intermediates
    • Cleaning & Housekeeping
    • Status Tags
    • Warehouse Audit
  • QC Laboratory & Testing
    • Analytical Method Validation
    • Chromatography Systems
    • Dissolution Testing
    • Assay & CU
    • Impurity Profiling
    • Stability & QC
    • OOS Investigations
    • OOT Trending
    • Sample Management
    • Reference Standards
    • Equipment Calibration
    • Instrument Qualification
    • LIMS & Electronic Data
    • Data Integrity
    • Microbiology QC
    • Sterility & Endotoxin
    • Environmental Monitoring
    • QC Documentation
    • Results Review
    • Method Transfer
    • Forced Degradation
    • Compendial Methods
    • Cleaning Verification
    • QC Deviations & CAPA
    • QC Lab Audits
  • Manufacturing & In-Process Control
    • Batch Manufacturing Records
    • Batch Manufacturing Records
    • Line Clearance
    • In-Process Sampling & Testing
    • Yield & Reconciliation
    • Granulation Controls
    • Blending & Mixing
    • Tablet Compression Controls
    • Capsule Filling Controls
    • Coating Process Controls
    • Sterile & Aseptic Processing
    • Filtration & Sterile Filtration
    • Visual Inspection of Parenteral
    • Packaging & Labelling Controls
    • Rework & Reprocessing
    • Hold Time for Bulk & Intermediates
    • Manufacturing Deviations & CAPA
  • Documentation, Training & QMS
    • SOP & Documentation Control
    • Training & Competency Management
    • Change Control & QMS Lifecycle
    • Internal Audits & Self-Inspection
    • Quality Metrics, Risk & Management Review
  • Production SOPs
  • QC Laboratory SOPs
    • Sample Management
    • Analytical Methods
    • HPLC & Chromatography
    • OOS & OOT
    • Data Integrity
    • Documentation
    • Equipment
  • Warehouse & Materials SOPs
    • Material Receipt
    • Sampling
    • Storage
    • Dispensing
    • Rejected & Returned
    • Cold Chain
    • Stock Control
    • Printed Materials
    • Pest & Housekeeping
  • Cleaning & Sanitization SOPs
  • Equipment & Qualification SOPs
  • Documentation & Data Integrity SOPs
  • Deviation/OOS/CAPA SOPs
    • Deviation Management
    • Root Cause
    • CAPA
    • OOS/OOT
    • Complaints
    • Recall
  • Training & Competency SOPs
    • Training System
    • Role-Based Training
    • OJT
    • Refresher Training
    • Competency
  • QA & QMS Governance SOPs
    • Quality Manual
    • Management Review
    • Internal Audit
    • Risk Management
    • Vendors & Outsourcing
  • About Us
  • Privacy Policy & Disclaimer
  • Contact Us

Copyright © 2025 Pharma GMP.

Powered by PressBook WordPress theme